Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Deadline for written submissions extended to 12:00 on Wednesday 15 November 2017
2017-11-08

Deadline for written submissions extended:  Investigation/review into the handling of student protests on the Bloemfontein and Qwaqwa campuses by private security companies during october 2017.

A panel, consisting of Mr Ashraf Mahomed and Ms Nomfundo Walaza, has been appointed by the University of the Free State (UFS) to investigate/review the handling of student protests on the Bloemfontein and Qwaqwa Campuses by private security companies during October 2017. 

Mr Ashraf Mahomed is an attorney and director at Ashraf Mahomed Attorneys in Cape Town. He specialises in constitutional law, administrative law, public law, alternative dispute resolution (including mediation, arbitration, negotiation and facilitation), and land reform law. Mr Mahomed serves as a board member of the Dullah Omar Institute (DOI) for Constitutional Law, Governance and Human Rights at the University of the Western Cape, as well as the Tshisimani Centre for Activist Education. He recently completed his second term as President of the Cape Law Society (CLS).
 
Ms Nomfundo Walaza is a clinical psychologist who has worked in the human rights field for the past two decades. For the past nine years, she has served as the CEO of the Desmond Tutu Peace Centre and also served for 11 years as the Executive Director of the Trauma Centre for Survivors of Violence and Torture in Cape Town. Ms Walaza is currently the Executive Director of PeaceSystems – a civil-society organisation that supports the development of sustainable institutions and systems that prevent, manage, and resolve conflict in African societies.
 
This is an independent panel, which was requested by the Rector and Vice-Chancellor of the UFS on behalf of the UFS Executive, and supported by the President of the Central Student Representative Council on behalf of the student body. 

Submissions by students and staff are awaited and can be submitted as follows:
 
1.       Written submissions
 
The deadline for written submissions has been extended to 12:00 on Wednesday 15 November 2017. Submissions can be sent to news@ufs.ac.za.
 
2.       Oral submissions

The panel will visit the campuses as follows to receive oral submissions:

Bloemfontein Campus:
Monday 13 November 2017
Time: 09:00-17:00 
Venue: SRC Chambers, Steve Biko Building

Kindly confirm attendance of the sessions by contacting Ms Rochelle Ferreira at +27 51 401 9808 or FerreiraR1@ufs.ac.za by 14:00 on Friday 10 November 2017.

Qwaqwa Campus:
Tuesday 14 November 2017
Time: 09:00-17:00 
Venue: Senate Hall, Intsika Building

Kindly confirm attendance of the sessions by contacting Ms Thabile Zuma at +27 58 718 5094 or ZumaMT@ufs.ac.za by 14:00 on Friday 2017. 

Enquiries can be directed to Mr JC van der Merwe at vdmjc@ufs.ac.za

 

Released by:
Lacea Loader (Director: Communication and Brand Management)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept